Literature DB >> 17683897

Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.

Jennifer M Taylor1, Melanie E Ziman, Don R Canfield, Michael Vajdy, Jay V Solnick.   

Abstract

The roles that T helper type 1 (Th1) and T helper type 2 (Th2) Helicobacter pylori-specific immune responses play in protection from H. pylori challenge are poorly understood. It is expected that Th2 immune responses are required for protection against extracellular bacteria, such as H. pylori. However, recent studies have suggested that Th1 immunity is required for protection. The mechanisms by which this might occur are unknown. Our goal in this study was to more clearly define the effects of a Th1- versus a Th2-promoting H. pylori vaccine on immunity and protection. Therefore, we tested a Th1 vaccine consisting of an H. pylori sonicate and CpG oligonucleotides (CpG) and a Th2 vaccine consisting of a lipopolysaccharide (LPS)-depleted H. pylori sonicate combined with cholera toxin (CT). We demonstrate that although the Th2-promoting vaccine induced stronger systemic and local immune responses, only the Th1-promoting vaccine was protective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683897      PMCID: PMC2234601          DOI: 10.1016/j.micpath.2007.06.006

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  45 in total

1.  Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.

Authors:  M J McCluskie; H L Davis
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

2.  Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa.

Authors:  Anna Lundgren; Christina Trollmo; Anders Edebo; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.

Authors:  Jennifer M Taylor; Melanie E Ziman; Jennifer L Huff; Nathan M Moroski; Michael Vajdy; Jay V Solnick
Journal:  Vaccine       Date:  2006-03-30       Impact factor: 3.641

Review 4.  The design of vaccines against Helicobacter pylori and their development.

Authors:  G Del Giudice; A Covacci; J L Telford; C Montecucco; R Rappuoli
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination.

Authors:  A H T Jeremy; Y Du; M F Dixon; P A Robinson; J E Crabtree
Journal:  Microbes Infect       Date:  2005-09-13       Impact factor: 2.700

6.  Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection.

Authors:  J Ikewaki; A Nishizono; T Goto; T Fujioka; K Mifune
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

7.  Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants.

Authors:  A E Kamradt; M Greiner; P Ghiara; S H Kaufmann
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

Review 8.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

9.  Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion.

Authors:  Wuxiong Cao; Yangde Chen; Sefik Alkan; Arun Subramaniam; Fan Long; Hong Liu; Rong Diao; Thomas Delohery; Jason McCormick; Rong Chen; Donghui Ni; Paul S Wright; Xin Zhang; Steve Busch; Asher Zilberstein
Journal:  Eur J Immunol       Date:  2005-09       Impact factor: 5.532

10.  SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans.

Authors:  Marina Aspholm; Farzad O Olfat; Jenny Nordén; Berit Sondén; Carina Lundberg; Rolf Sjöström; Siiri Altraja; Stefan Odenbreit; Rainer Haas; Torkel Wadström; Lars Engstrand; Cristina Semino-Mora; Hui Liu; André Dubois; Susann Teneberg; Anna Arnqvist; Thomas Borén
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

View more
  19 in total

1.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

2.  Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.

Authors:  Maelíosa T C McCrudden; Barbara M Torrisi; Sharifah Al-Zahrani; Cian M McCrudden; Marija Zaric; Christopher J Scott; Adrien Kissenpfennig; Helen O McCarthy; Ryan F Donnelly
Journal:  J Pharm Pharmacol       Date:  2014-03-27       Impact factor: 3.765

3.  Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.

Authors:  Lin Lü; Han-qing Zeng; Pi-long Wang; Wei Shen; Ting-xiu Xiang; Zhe-chuan Mei
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

4.  Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma.

Authors:  Li-Jun Xue; Xiao-Bei Mao; Xiao-Bei Liu; Han Gao; Ya-Nan Chen; Ting-Ting Dai; Sheng-Wen Shao; Hong-Min Chen; Xiao-Yuan Chu
Journal:  Cancer Biol Ther       Date:  2019-02-20       Impact factor: 4.742

5.  Disruption of sncRNA Improves the Protective Efficacy of Outer Membrane Vesicles against Helicobacter pylori Infection in a Mouse Model.

Authors:  Biaoxian Li; Yilian Xu; Tian Xu; Zhicheng Guo; Qianwen Xu; Yi Li; Lingbin Zeng; Xiaotian Huang; Qiong Liu
Journal:  Infect Immun       Date:  2022-07-21       Impact factor: 3.609

Review 6.  Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe?

Authors:  Camila A Figueiredo; Cintia Rodrigues Marques; Ryan dos Santos Costa; Hugo Bernardino F da Silva; Neuza M Alcantara-Neves
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

7.  Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli.

Authors:  Xinghong Yang; Theresa Thornburg; Kathryn Holderness; Zhiyong Suo; Ling Cao; Timothy Lim; Recep Avci; David W Pascual
Journal:  J Biomed Biotechnol       Date:  2011-10-09

8.  Immunization with Heat Shock Protein A and γ-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice.

Authors:  Xiaoli Zhang; Jinyong Zhang; Feng Yang; Weiru Wu; Heqiang Sun; Qinghua Xie; Weike Si; Quanming Zou; Zhong Yang
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

9.  Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.

Authors:  Bin Li; Li Chen; Heqiang Sun; Wuchen Yang; Jian Hu; Yafei He; Shanshan Wei; Zhuo Zhao; Jinyong Zhang; Haibo Li; Quanming Zou; Chao Wu
Journal:  Sci Rep       Date:  2015-10-05       Impact factor: 4.379

10.  Lower circulating levels of chemokine CXCL10 in Helicobacter pylori-infected patients with peptic ulcer: Influence of the bacterial virulence factor CagA.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Mohammad Taghi Rezayati; Hossain Khoramdel; Mansooreh Nabizadeh; Gholamhossain Hassanshahi; Hamid Abdollahi
Journal:  Iran J Microbiol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.